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Associations between daily air quality and hospitalisations 
for acute exacerbation of chronic obstructive pulmonary 
disease in Beijing, 2013–17: an ecological analysis
Lirong Liang*, Yutong Cai*, Benjamin Barratt, Baolei Lyu, Queenie Chan, Anna L Hansell, Wuxiang Xie, Di Zhang, Frank J Kelly, Zhaohui Tong
Summary
Background Air pollution in Beijing has been improving through implementation of the Air Pollution Prevention and 
Control Action Plan (2013–17), but its implications for respiratory morbidity have not been directly investigated. We 
aimed to assess the potential effects of air-quality improvements on respiratory health by investigating the number of 
cases of acute exacerbations of chronic obstructive pulmonary disease (COPD) advanced by air pollution each year.
Methods Daily city-wide concentrations of PM10, PM2·5, PMcoarse (particulate matter >2·5–10 µm diameter), nitrogen 
dioxide (NO2), sulphur dioxide (SO2), carbon monoxide (CO), and ozone (O3) in 2013–17 were averaged from 
35 monitoring stations across Beijing. A generalised additive Poisson time-series model was applied to estimate the 
relative risks (RRs) and 95% CIs for hospitalisation for acute exacerbation of COPD associated with pollutant 
concentrations.
Findings From Jan 18, 2013, to Dec 31, 2017, 161 613 hospitalisations for acute exacerbation of COPD were recorded. 
Mean ambient concentrations of SO2 decreased by 68% and PM2·5 decreased by 33% over this 5-year period. For each 
IQR increase in pollutant concentration, RRs for same-day hospitalisation for acute exacerbation of COPD 
were 1·029 (95% CI 1·023–1·035) for PM10, 1·028 (1·021–1·034) for PM2·5, 1·018 (1·013–1·022) for PMcoarse, 
1·036 (1·028–1·044) for NO2, 1·019 (1·013–1·024) for SO2, 1·024 (1·018–1·029) for CO, and 1·027 (1·010–1·044) for 
O3 in the warm season (May to October). Women and patients aged 65 years or older were more susceptible to the 
effects of these pollutants on hospitalisation risk than were men and patients younger than 65 years. In 2013, there 
were 12 679 acute exacerbations of COPD cases that were advanced by PM2·5 pollution above the expected number of 
cases if daily PM2·5 concentrations had not exceeded the WHO target (25 μg/m³), whereas the respective figure in 
2017 was 7377 cases.
Interpretation Despite improvement in overall air quality, increased acute air pollution episodes were significantly 
associated with increased hospitalisations for acute exacerbations of COPD in Beijing. Stringent air pollution control 
policies are important and effective for reducing COPD morbidity, and long-term multidimensional policies to 
safeguard public health are indicated.
Funding UK Medical Research Council.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Chronic obstructive pulmonary disease (COPD) is a 
leading contributor to disease burden globally.1 A survey 
in China2 showed an estimated nationwide prevalence of 
spirometry-defined COPD of 13·7% among people aged 
40 years and older in 2012–15, a 5·5% increase from 
the 2002–04 survey, and suggested ambient air pollution 
resulting from rapid urbanisation as a probable con-
tributor to this emerging COPD epidemic.
Although ambient air pollution might contribute to a 
more rapid decline of lung function and subsequent onset 
of COPD in adults,3,4 its adverse effects on patients with 
existing COPD have also been widely reported. Short-term 
exposure to air pollution has been positively associated 
with COPD-related emergency department visits, hospital 
admissions, and mortality.5,6 However, not all of these 
studies have specifically focused on acute exacerbations of 
COPD, an outcome that is often associated with COPD 
progression and prognosis, repeated access to health care, 
impaired quality of life, and mortality. A systematic review6 
of 46 studies on acute exacerbations of COPD published 
until 2015 revealed heterogeneous evidence across studies 
in geographically diverse regions, but included few 
epidemiological studies from regions with severe ambient 
air pollution. Increasing numbers of studies have been 
reported from such regions in the past 4 years regarding 
short-term and long-term associations between air 
pollution and respiratory morbidity and mortality to help 
strengthen the evidence base.1,5,7,8 Additionally, from both 
clinical and policy perspectives, important knowledge 
gaps remain concerning the exposure–response relation- 
ships between extremely high concentrations of ambient 
air pollution and risk of hospitalisation for acute 
exacerbation of COPD.
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In 2013, China launched the Air Pollution Prevention 
and Control Action Plan (APPCAP), in which various 
stringent measures9 (appendix p 3) were implemented 
nationwide to curb air pollution, particularly that from 
industrial sectors, to interim targets by the end of 2017.10 
Beijing and the surrounding areas were among the most 
stringently targeted regions. During this 5-year period, 
concentrations of sulphur dioxide (SO2) were reduced by 
70% and fine particulate matter (PM) by 33%.10 This 
progress provides an opportunity to study the potential 
health gains of this milestone policy.
In the current study, we investigated the associations 
between daily average concentrations of criteria air pol-
lutants and daily hospitalisations for acute exacer bations 
of COPD in 2013–17 in Beijing. On the basis of the 
observed effect estimates, we calculated the number of 
cases of acute exacerbations of COPD advanced by air 
pol lution each year to assess the potential effects of the 
recorded air-quality improvements.
Methods
Study setting and exposure data
Since 2013, PM10 (μg/m³), PM2·5 (μg/m³), SO2 (μg/m³), 
nitrogen dioxide (NO2; μg/m³), carbon monoxide 
(CO; mg/m³) and ozone (O3; μg/m³) have been routinely 
measured at 35 monitoring stations spread throughout 
Beijing (appendix p  2). The monitoring network is 
run by the Beijing Environmental Protection Bureau in 
accordance with the new Chinese national standard 
(GB 3095-2012). The monitoring stations were strategically 
assigned in representative locations to monitor emission 
sources from vehicles (road site, n=5), urban anthropogenic 
activities (urban site, n=23), natural activities (rural site, 
n=1), and regional transport or background (regional site 
on the outskirts of Greater Beijing, n=6). At each station, 
for each pollutant except O3, hourly data are usually 
available for at least 20 h each day to calculate the daily 
24-h average (mean) concentration. For O3, hourly data 
should be available for at least 6 h in every 8 h to calculate 
a daily maximum 8-h moving average concentration.
A daily city-wide mean concentration for each pollutant, 
based on the daily mean readings from all these 
35 stations, is reported on the Environmental Protection 
Bureau air-quality reporting platform. We obtained these 
daily city-wide average data from Jan 18, 2013, to 
Dec 31, 2017 (1809 days), and the quality check was 
satisfied (appendix p 4). Daily meteorological data (daily 
mean temperature [°C] and relative humidity [%]) were 
collected from the Beijing Meteorological Service 
website.
Research in context
Evidence before this study
We searched PubMed to identify systematic reviews of 
epidemiological studies on short-term air pollution and hospital 
admissions for chronic obstructive pulmonary disease (COPD), 
using a combination of search terms: “air pollution”, “COPD”, 
“hospital admission”, and “meta-analysis” or “systematic review”. 
The search was limited to studies that pooled results on a global 
scale, reported analytical pooled estimates, were written in 
English, and were published between Jan 1, 2013, and 
Dec 31, 2017. According to systematic reviews, numerous studies 
have reported that short-term increases in air pollution are 
significantly associated with COPD morbidity. However, the 
evidence was heterogeneous across studies in geographically 
diverse regions. Air pollution health responses in the Chinese 
population might differ from those of European and North 
American studies because of differences in the air pollution 
mixture and underlying health statuses of these populations. 
In 2013, the Air Pollution Prevention and Control Action Plan 
(APPCAP) was launched by the Chinese Government to curb air 
pollution to interim target concentrations by 2017. Reports have 
indicated that air quality has been improving during this period in 
China. However, no Chinese studies to date have directly 
investigated the implications of APPCAP on acute exacerbations 
of COPD, an important clinical and health-care problem.
Added value of this study
Although annual average concentrations of most pollutants 
have decreased from 2013 to 2017 in Beijing, significant positive 
associations with hospitalisations for acute exacerbations of 
COPD were still observed for both particulate and gaseous 
pollutants. However, the number of cases of acute exacerbation 
of COPD advanced by PM2·5 pollution exceeding the WHO 24-h 
PM2.5 target, as well as the associated health-care costs, was 
estimated to be reduced by nearly 42% from 2013 to 2017. 
To date, this study is the largest in China to investigate the 
associations between short-term air pollution exposures and 
acute exacerbations of COPD at a city level in a period when air 
quality is progressively improving. It is also the first study in 
China to show that implementation of a stringent air pollution 
control policy is beneficial for reducing COPD morbidity at the 
population level.
Implications of all the available evidence
In Beijing, the annual mean concentration of PM2·5 was reduced 
from 87 µg/m³ in 2013 to 58 µg/m³ in 2017. However, this 2017 
concentration is still almost six times higher than the WHO 
target value of 10 µg/m³. Concentrations of some gaseous 
pollutants such as nitrogen dioxide and ozone remained stable 
over this period, indicating that controls against emissions of 
these pollutants need to be more strictly enforced, given that 
these pollutants also have adverse effects on respiratory health. 
Although our study highlights the positive health gains of 
APPCAP among patients with COPD, continuous monitoring of 
air quality and a long-term, multidimensional air pollution 
control policy are needed to safeguard public health and 
sustainable development in China.
For the Environmental 
Protection Bureau air-quality 
reporting platform see http://
zx.bjmemc.com.cn/
See Online for appendix
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Of the 1809 days, there were 5 days with a missing city-
wide daily average for all pollutants, which were excluded 
from the analysis. In the remaining 1804 days, a city-wide 
daily average was available for all pollutants, except 
5 days of missing data and 97 days of distorted data for 
daily city-wide average PM10 (appendix p 4), and 34 days 
of missing daily city-wide average O3. To reconstruct the 
missing or distorted PM10 data for those 102 days, we 
used 24-h average concentrations for PM2·5 on the same 
date multiplied by the ratio between annual mean 
concentration for PM10 and annual mean concentration 
for PM2·5 derived for that year. The annual ratios derived 
were 1·312 for 2013, 1·444 for 2014, 1·441 for 2015, 
1·379 for 2016, and 1·631 for 2017, which were similar to 
previously reported results.11 We did not reconstruct data 
on O3 because of the complex formation mechanism of 
this pollutant. Therefore, our analyses of PM10, PM2·5, 
PMcoarse (defined as PM >2·5–10  μm in diameter), SO2, 
NO2, and CO were based on the 1804-day dataset, and the 
analyses of O3 were based on a 1770-day dataset.
This study was approved by the Research Ethics Board 
of Beijing Chaoyang Hospital (approval number 
2018-ke-303).
Hospital data
Daily counts of hospital admissions for acute exacer-
bation of COPD were obtained from a hospital discharge 
database operated by Beijing Public Health Information 
Centre. In Beijing, each government and private hospital 
at secondary or tertiary level is required to submit their 
discharge records to the database.12 A three-tier health-
care system is operated in China, where secondary and 
tertiary level hospitals are general hospitals eligible to 
provide specialised care.13 Each record includes data on 
age, sex, residential address, admitting hospital, date of 
admission, health-care cost, principal discharge diag-
nosis, and the corresponding International Classifi-
cation of Diseases tenth revision (ICD-10) code following 
standard procedures. Using this information, we in-
cluded patients with a primary discharge diagnosis of 
acute exacerbation of COPD (ICD-10 J44.0-J44.9), who 
were aged 18 years or older, and who were living in 
Beijing on a permanent basis. All admissions for acute 
exacerbation of COPD were from 119 hospitals 
(68 tertiary and 51 secondary).
Statistical analysis
Daily hospitalisations for acute exacerbation of COPD, 
pollutant concentrations, and meteorological variables 
in 2013–17 were linked by date to allow a time-series 
analysis. We defined same-day exposure as lag0 and 
examined a priori daily exposure up to 4 days 
(single-day lag0 to lag4 and moving average of lag0–2 
and lag0–4 concentrations) before hospitalisation, based 
on a systematic review.6 The associations between daily 
hospitalisations for acute exacerbation of COPD and 
average concentration of each pollutant were analysed 
with a generalised additive model estimating Poisson 
distribution, as follows: 
where E(Yt) represents the number of cases of acute 
exacerbation of COPD on day t; C is the city-averaged 
concentration; i is the day lag; β represents the log-
relative risk (RR) of hospitalisation for acute exacerbation 
of COPD associated with a unit increase in each pollutant 
mean concentration; ps() indicates penalised spline 
function to filter out long-term trends and seasonal 
patterns in daily hospitalisations for acute exacerbation 
of COPD;14 temp is the daily mean temperature (°C); and 
RH is relative humidity (%). Public holiday and day of 
week were included as categorical variables. Degrees of 
freedom for calendar time, temperature, and relative 
humidity were selected based on the parameters used in 
previous studies.15–17
Apart from the single-pollutant models, we also 
investigated each association in two-pollutant models if 
Spearman correlation ratios between these pollutants 
were less than 0·7.18 Subgroup analyses at lag0 were done 
by age (18–64 years and ≥65 years), sex, and season 
(warm season [May to October] or cold season 
[November to April]). The Z test was used to compare the 
two estimates derived from each subgroup.
The smoothing function of the generalised additive 
model was used to graphically analyse the exposure–
response relationships between the log-RR of 
hospitalisation for acute exacerbation of COPD and air 
pollutant concentrations at lag0.
For each single year from 2013 to 2017, we re-ran the 
main analyses for the associations between each air 
pollutant and acute exacerbations of COPD hospital-
isation risk at lag0.
We did several sensitivity analyses by altering the 
generalised additive model: to exclude calendar time, as 
long-term trends and seasonal patterns might also be 
partly related to pollutant concentration; to replace 
calendar time with an interaction term of exposure-by-
season; to increase the degrees of freedom of 
temperature and humidity to six; and to model moving 
averages for lag0–4 of temperature and humidity instead 
of the current day (lag0). The latter two analyses were to 
adjust potential non-linear and lagged confounding 
effects of weather conditions.5 Finally, we excluded the 
102 days with reconstructed data for PM10 from the 
1804-day dataset and re-ran the main analysis.
Using the following equation, we calculated the number 
of cases of acute exacerbations of COPD advanced by 
PM2·5, as an overall air-quality indicator, over the expected 
rates if daily concentrations had not exceeded the target in 
each year from 2013 to 2017:12 
log[E(Yt)] = intercept + βC – i + ps(calendar time, 9) + 





( × PARFlag0  × N)
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where PMt was the city-wide average concentration of 
PM2·5 on day t; PARF represents the population-
attributable risk fraction, calculated as (RR – 1) divided by 
RR, assuming the prevalence of air pollution exposure 
was 100%; and N is the daily mean number of cases in a 
particular year.
All statistical analyses were done in R (version 3.0.2) 
using the MGCV, DPLYR, and TTR packages. RRs of 
hospitalisation for acute exacerbation of COPD per IQR 
increase for each air pollutant were calculated.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
During 2013–17, the daily mean concentration of PM10 
was 109·7 µg/m³ and of PM2·5 was 76·7 µg/m³ (table 1), 
both of which were considerably higher than the current 
Chinese grade I ambient air-quality standard (target 24-h 
mean concentrations 50 μg/m³ for PM10 and 35 μg/m³ 
for PM2·5) or WHO guidelines (target 50 μg/m³ for PM10 
and 25 μg/m³ for PM2·5). 161 613 hospitalisations for 
acute exacerbation of COPD were recorded (mean 
89 per day), with most patients being men and people 
aged 65 years or older.
Over the 5-year period studied, annual mean SO2 
concentration decreased by 68% (from 24·5 μg/m³ [SD 
23·2] in 2013 to 7·7 μg/m³ [8·4] in 2017) and PM2·5 
concentration by 33% (from 86·8 μg/m³ [65·8] to 
57·7  μg/m³ [55·5]), whereas the concentration of O3 
remained stable (figure 1; appendix p 5). Concentrations of 
PM10, PM2·5, NO2, and CO were lowest in summer (June to 
August) and highest in winter (November to February) 
(appendix p 6), but the opposite trend was observed for O3. 
Concentrations of PMcoarse were consistently higher in 
spring (March to May). PM10, PM2·5, NO2, and CO 
concentrations showed strong positive correlations with 
one another (Spearman’s r>0·7), whereas PMcoarse and PM2·5 
showed a weak positive correlation (r=0·247; appendix 
p 9). SO2 concentration showed moderate positive 
correlations with concentrations of PM10, PM2·5, and NO2, 
and CO (r>0·4 to <0·7).
In single-pollutant models at lag0, the RR of 
hospitalisation for acute exacerbation of COPD per 
IQR increase in pollutant was 1·029 (95% CI 
1·023–1·035) for PM10, 1·028 (1·021–1·034) for PM2·5, 
1·018 (1·013–1·022) for PMcoarse, 1·036 (1·028–1·044) for 
NO2, 1·019 (1·013–1·024) for SO2, and 1·024 (1·018–1·029) 
for CO (figure 2; appendix pp 10–12). All these effect 
estimates were highest at lag0 and showed a decreasing 
trend to lag4. These results did not substantially change 
in most of the two-pollutant models, except that the 
associations with PMcoarse or SO2 became non-significant 
when PM10 was further adjusted (appendix pp 14–17). 
Associations with moving-day average (lag0–2 and 
lag0–4) exposures were significant in both single-
pollutant and two-pollutant models for all pollutants, 
with effect estimates similar to those seen at lag0.
In the warm season, increased O3 exposures at lag0 and 
lag0–2 were significantly associated with increased 
Minimum Maximum Mean (SD) Median (IQR)
Air pollutant concentrations
PM10, μg/m³ 10·0 820·0 109·7 (79·1) 91·0 (54·0–140·0)
PM2·5, μg/m³ 5·0 467·0 76·7 (66·7) 58·0 (29·0–101·0)
PMcoarse, μg/m³ 0·0 461·0 33·0 (29·1) 27·0 (16·0–41·0)
NO2, μg/m³ 8·0 155·0 50·5 (24·2) 44·0 (33·0–63·0)
SO2, μg/m³ 2·0 139·0 15·1 (18·4) 8·0 (4·0–19·0)
O3, μg/m³ 2·0 292·0 95·8 (62·2) 83·0 (50·0–135·0)
CO, mg/m³ 0·2 8·0 1·2 (1·0) 0·9 (0·6–1·4)
Meteorological measures
Temperature, °C –16·0 32·0 13·1 (11·0) 14·0 (2·0–23·0)
Relative humidity, % 8·0 97·0 53·2 (20·1) 53·0 (38·0–69·5)
Hospital admissions (number of cases per day)
Total 17 220 89 (36) 89 (60–113)
Female 2 90 29 (14) 27 (18–37)
Male 9 153 60 (23) 62 (39–76)
Age <65 years 0 43 14 (7) 14 (9–19)
Age ≥65 years 13 184 75 (30) 75 (51–94)
Warm season, May to October 17 168 80 (30) 82 (52–102)
Cool season, November to April 19 220 99 (38) 99 (68–126)
Data are for 1804 days (or 1770 days for O3) from 2013 to 2017. Air pollutant concentrations are 24-h averages, except 
for O3 concentrations, which are 8-h averages. PM=particulate matter. NO2=nitrogen dioxide. SO2=sulphur dioxide. 
O3=ozone. CO=carbon monoxide.
Table 1: Air pollutant concentrations, weather conditions, and daily hospital admissions for acute 
exacerbation of chronic obstructive pulmonary disease in Beijing
Figure 1: Annual mean average concentrations of the six criteria air 
pollutants in Beijing in 2013–17 as percentages of the Chinese grade II target 
annual concentrations
The dashed line denotes the Chinese grade II target annual concentration. Values 
are the percentage increase or decrease of each concentration relative to the 
target concentration (0%). CO=carbon monoxide. NO2=nitrogen dioxide. 
O3=ozone. PM=particulate matter. SO2=sulphur dioxide.
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Figure 2: RR of 
hospitalisation for acute 
exacerbation of COPD 
associated with pollutants in 
single-pollutant and 
two-pollutant models at 
different lag days during 
2013–17
Data are RR (95% CI) per 












































































































































































CO only CO and SO2
SO2 only SO2 and PM2·5
NO2 only NO2 and SO2
PMcoarse only PMcoarse and SO2
PM2·5 only PM2·5 and SO2
PM10 only PM10 and SO2
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hospitalisations for acute exacerbations of COPD 
(table 2), for which the association persisted after further 
adjustment for NO2 or CO, but not for PM (except PMcoarse 
at lag0). In the cold season at lag0, O3 was significantly 
associated with decreased hospitalisations for acute 
exacerbation of COPD in all models, as was O3 at lag0–2 
and lag0–4, except in the model also adjusted for CO.
At lag0, for all pollutants except PMcoarse and O3, larger 
effect estimates were seen in women than in men, and in 
people aged 65 years or older than in those younger than 
65 years (Z test p<0·05; appendix p 7). Effect estimates for 
PM2·5 were significantly higher in the warm season than 
in the cold season.
Positive exposure–response curves at lag0 were observed 
at least up to 400 µg/m³ for PM10 and up to 300 µg/m³ for 
PM2·5, whereas no saturation effect was observed for 
PMcoarse even up to 400 µg/m³ (figure 3). Various patterns 
were observed for the gaseous pollutants (figure 3).
The yearly coefficients at lag0 for most pollutants 
fluctuated throughout 2013–17 (appendix p 8).
Results from all sensitivity analyses were generally in 
line with the main results (figure 2). When the time 
variable was excluded (appendix p 18) or replaced with an 
exposure-by-season interaction term (appendix p 19), all 
significant associations persisted but the effect estimates 
increased. When the degrees of freedom of weather 
conditions were increased (appendix p 20), the results 
remained very similar to those of the main analysis 
(figure 2). Additionally, when the moving average of lag 
effects of weather conditions was modelled (appendix 
p 21), effect estimates were slightly reduced but remained 
significant. Results also did not change substantially 
after excluding days with missing or distorted PM10 data 
(appendix p 22).
The number of days that city-averaged PM2·5 concen- 
tration exceeded the WHO 24-h target (25 µg/m³) was 
reduced from 298 in 2013 to 256 in 2017 (table 3). There 
was a decreasing trend in the number of cases of acute 
exacerbations of COPD advanced by PM2·5 pollution 
above the expected rates if daily concentrations had not 
exceeded either the Chinese or WHO targets (table 3). 
Based on the WHO 24-h target, the number of acute 
exacerbations of COPD cases advanced by PM2·5 was 
12 679 in 2013 and 7377 in 2017, corresponding to a 
decrease of nearly 42% between those two timepoints. A 
similar percentage reduction was observed for health-
care cost (table 3).
Discussion
We found significant associations between short-term 
exposures to air pollution and hospitalisations for acute 
exacerbation of COPD, with RRs at lag0 ranging from 
1·018 to 1·036 for each IQR increase in concentration. 
By lag4, most of these increased risks became non-
significant. Effects of moving-day average exposures 
(lag0–2 and lag0–4) were also statistically significant and 
similar to those seen at lag0. Women and patients aged 
65 years or older were most susceptible. The shapes of 
each exposure–response relationship varied greatly by 
type of pollutant in our study, which probably reflects the 
variations in biological mechanisms and characteristics, 
including toxicity, of each pollutant.
Our effect estimates expressed per 10 µg/m³ increase 
(appendix p 13) were generally lower, especially for PM, 
than those in other Asian studies done at least a decade 
ago (appendix p 24). Although the study populations and 
sources of PM2·5 data were not directly comparable, our 
effect estimate per 10 µg/m³ increase of PM2·5 at lag0 
O3 only O3 and PM10 O3 and PMcoarse O3 and PM2·5 O3 and NO2 O3 and CO O3 and SO2
Warm season (May to October)
Lag0 1·027 (1·010–1·044)* 1·008 (0·991–1·025) 1·022 (1·005–1·039)* 1·006 (0·989–1·023) 1·025 (1·008–1·042)* 1·025 (1·008–1·042)* 1·018 (1·001–1·035)*
Lag1 1·019 (1·004–1·035)* 1·009 (0·994–1·025) 1·017 (1·001–1·033)* 1·011 (0·996–1·027) 1·019 (1·004–1·035)* 1·019 (1·004–1·034)* 1·015 (0·999–1·031)
Lag2 1·004 (0·990–1·018) 0·996 (0·982–1·011) 1·002 (0·988–1·016) 0·997 (0·983–1·012) 1·004 (0·989–1·018) 1·003 (0·989–1·018) 1·003 (0·988–1·019)
Lag3 1·000 (0·986–1·014) 0·994 (0·979–1·008) 0·998 (0·984–1·013) 0·994 (0·980–1·009) 0·999 (0·985–1·013) 1·000 (0·986–1·014) 1·002 (0·987–1·017)
Lag4 0·995 (0·982–1·009) 0·991 (0·977–1·006) 0·993 (0·980–1·007) 0·993 (0·978–1·007) 0·994 (0·980–1·008) 0·995 (0·981–1·009) 0·991 (0·976–1·005)
Lag0–2 1·027 (1·007–1·048)* 1·006 (0·985–1·027) 1·019 (0·998–1·040) 1·010 (0·989–1·030) 1·028 (1·008–1·048)* 1·026 (1·006–1·047)* 1·016 (0·995–1·038)
Lag0–4 1·019 (0·996–1·042) 1·001 (0·978–1·025) 1·011 (0·988–1·034) 1·006 (0·983–1·029) 1·023 (1·000–1·047) 1·019 (0·997–1·043) 1·007 (0·983–1·032)
Cool season (November to April)
Lag0 0·952 (0·936–0·969)* 0·957 (0·941–0·974)* 0·960 (0·943–0·977)* 0·955 (0·938–0·971)* 0·964 (0·947–0·982)* 0·966 (0·949–0·984)* 0·955 (0·938–0·972)*
Lag1 0·970 (0·956–0·985)* 0·982 (0·967–0·998)* 0·975 (0·960–0·989)* 0·979 (0·963–0·995)* 0·984 (0·967–1·002) 0·989 (0·973–1·007) 0·975 (0·960–0·991)*
Lag2 0·991 (0·977–1·005) 0·997 (0·982–1·012) 0·992 (0·978–1·006) 0·996 (0·981–1·011) 0·993 (0·977–1·009) 1·001 (0·985–1·018) 0·989 (0·975–1·004)
Lag3 0·988 (0·974–1·001) 0·989 (0·975–1·004) 0·988 (0·975–1·002) 0·988 (0·974–1·003) 0·980 (0·965–0·996)* 0·989 (0·973–1·005) 0·986 (0·972–1·001)
Lag4 0·988 (0·975–1·002) 0·990 (0·976–1·005) 0·989 (0·975–1·003) 0·988 (0·973–1·003) 0·979 (0·963–0·995)* 0·988 (0·972–1·005) 0·986 (0·972–1·001)
Lag0–2 0·956 (0·937–0·976)* 0·969 (0·948–0·990)* 0·963 (0·943–0·983)* 0·964 (0·943–0·985)* 0·970 (0·948–0·992)* 0·979 (0·957–1·002) 0·959 (0·939–0·979)*
Lag0–4 0·960 (0·939–0·981)* 0·972 (0·950–0·994)* 0·963 (0·942–0·984)* 0·967 (0·945–0·989)* 0·963 (0·940–0·987)* 0·980 (0·955–1·005) 0·961 (0·940–0·982)*
Data are relative risk (95% CI). O3=ozone. PM=particulate matter. NO2=nitrogen dioxide. CO=carbon monoxide. SO2=sulphur dioxide. *Statistically significant (p<0·05).
Table 2: Associations between daily average concentration of O3 (per IQR of 85 μg/m³ higher) and daily hospital admissions for acute exacerbation of chronic obstructive pulmonary 
disease in Beijing (2013–17, 1770 days) in single-pollutant and two-pollutant models
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(1·004 [95% CI 1·003–1·005]; appendix p 25) was lower 
than those reported in previous studies of Beijing 
residents conducted in 2010–12 (1·007 [1·006–1·007])16 
and in 2013 (1·015 ([1·001–1·028]).19
APPCAP has mainly targeted heavy industries and has 
resulted in an appreciable reduction in concentrations of 
SO2 and PM2·5 in Beijing. It is likely that the compositions 
of air pollutant mixtures will have changed (eg, lower 
sulphur compositions) over the years, and that these 
changes could have positive effects on health. A 2018 study 
of 74 cities in China estimated substantial reductions in 
mortality as an effect of APPCAP.9 This finding is further 
supported by our estimation of decreased numbers of 
cases of acute exacerbations of COPD advanced by PM2·5 
pollution, highlighting the effectiveness of such air 
pollution control policy in reducing respiratory morbidity. 
However, lasting health benefits from improved air quality 
remain to be confirmed. A long-term, multidimensional 
air pollution control strategy is needed in China to 
safeguard public health and reduce health-care costs.
It has been hypothesised that air pollutants could 
induce airway epithelial damage, inhibit mucociliary 
clearance, and impair macrophage function through 
activation of inflammatory cells and their mediators as 
well as through promotion of intracellular oxidative 
stress.20 These pathways might either directly trigger an 
exacerbation, or collectively create a pulmonary micro-
environment with impaired immune function that 
makes the host more susceptible to viral and bacterial 
infections—the major causes of acute exacerbations of 
COPD. Besides the physical and chemical compositions 
of pollutants that might, in part, underlie the mechanisms 
leading to acute exacerbations of COPD, some airborne 
microbes (eg, pathogenic bacteria and fungi) might also 
play a role.21
Relatively few studies22 have investigated the short-
term effects of PMcoarse on acute exacerbations of COPD. 
In our study, the exposure–response curve followed a 
non-linear pattern, being steeper at lower concen trations 
but shallower at higher concentrations, and no saturation 
effect was evident. This finding indicates that PMcoarse (or, 
similarly, PM2·5), even at a relatively low concentration, 
could increase risk of acute exacerbation events in 
COPD, although the threshold for so-called safe concen-
trations remains to be established. Previous studies have 
reported that PMcoarse has short-term health effects at 
least as strong as those of PM2·5, but the effects of PMcoarse 
were generally higher for respiratory than for cardio-
vascular outcomes because of the physical and chemical 
differences in these particles.22 Unlike PM2·5 which can 
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Figure 3: Exposure–response relationships between each pollutant and 
hospitalisation for acute exacerbation of COPD in single-pollutant models at 
lag0 during 2013–17
Red tick marks along the x-axes represent individual observations. CO=carbon 
monoxide. COPD=chronic obstructive pulmonary disease. NO2=nitrogen dioxide. 
O3=ozone. PM=particulate matter. RR=relative risk. SO2=sulphur dioxide. 
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travel deep into the respiratory system to the alveoli and 
terminal bronchioles, and even cross the air–blood 
barrier, PMcoarse is mainly deposited in the primary 
bronchi. PMcoarse is formed of more visible forms of 
PM, including road dust, soil, and black smoke.23 In 
epidemiological studies, PMcoarse, but not PM2·5, was 
associated with an increased prevalence of respiratory 
symptoms,24,25 indicating that PMcoarse might have a 
greater role in the triggering of acute exacerbations of 
COPD than does PM2·5. Beijing is often affected by dust 
storms with extremely high concentrations of coarse 
particles, and studies have suggested a link between 
these dust storms and hospitalisations for respiratory 
disease.26,27 The significance of our findings for PMcoarse 
appeared unaffected by adjustment for PM2·5, but 
epidemiological and toxicological evidence of the effects 
of coarse particles on respiratory outcomes warrants 
further investigation.
Very few studies from Asia have explored the acute 
effects of CO and the risk of acute exacerbations of 
COPD. In our study, we observed a 3% increase in acute 
exacerbations of COPD per 1 mg/m³ increase in CO at 
lag0 (appendix p 13), consistent with pooled estimates 
reported for Europe (4%) and North America (2%).6 
However, two studies in Shanghai28 and Hong Kong29 
have shown that low ambient concentrations of CO are 
protective against COPD exacerbation, even after co-
adjusting for other traffic-related pollutants. Both studies 
cautiously suggested that this link is possible because 
low concentrations of CO can have anti-inflammatory 
and antimicrobial effects, as reported in both experi-
mental and human studies.28,30,31 Our study had similarly 
low concentrations of CO, but the correlations between 
CO and other traffic-related pollutants (PM2·5 and NO2) in 
our study were high, which precluded co-adjustments 
with these pollutants.
Ambient concentrations of SO2 in China have 
decreased markedly since 2013,9,32 as supported by our 
data, mainly because of strict control measures among 
industries and a steady structural change in energy 
consumption. Despite this reduction, over this 5-year 
period, we found a modest positive association between 
SO2 and hospitalisations for acute exacerbations of 
COPD, even after adjusting for PM2·5. The significant 
association between exacerbations and SO2 observed in 
2013 seem to diminish over the years to 2017, a pattern 
that was not seen for other pollutants. However, this 
finding needs cautious interpretation until air pollution 
concentrations for future years become available to allow 
the effects of long-term air-quality improvement on 
health gains to be studied.
The concentrations of O3 remained stable from 2013–17. 
Background O3 concentrations might remain relatively 
constant for many years in urban areas in China, and 
even increase if measures against nitrogen oxides (NOX) 
emissions are adopted rigorously, as shown in Europe 
and North America.33 The Global Burden of Disease 
study estimated that about 254 000 deaths from COPD in 
2015 were attributable to O3.34 Given this context, and that 
our results for O3 during the warm season were robust to 
adjustments for some other gaseous pollutants, con-
tinuous monitoring and mitigation measures for O3 are 
needed.
The seasonal effects of O3 on acute exacerbations of 
COPD remain unclear, as we observed positive 
associations in the warm season but negative associations 
in the cold season. In Beijing, concentrations of O3 
during the warm season are high, and people tend to go 
outdoors and open windows more often; in the cold 
season, concentrations are low, while people mostly stay 
indoors and ventilation is reduced because of heating. 
These differential behaviours of individuals could also 
partly explain the higher effect estimates for PM10 
and PM2·5 in the warm season. Additionally, high 
temperatures might have a synergistic role.35 As with 
two other studies of Beijing residents,16,19 we found that 
women with COPD were more susceptible to acute air 
pollution effects. Patients aged 65 years and older were 
also susceptible because they are likely to have a com-
promised immune system, and the health of patients 
with COPD generally deteriorates rapidly after 65 years 
of age.
As with many previous studies, we have only considered 
the temporal variations of the effects of air pollutants 
on  hospitalisations for acute exacerbations of COPD. 
However, spatial variations of these health effects should 
not be disregarded, especially in megacities such as 
Beijing, where spatial variation in concentrations of air 
pollutants could vary greatly. The southern part of 
Greater Beijing reportedly has worse air quality than that 
in the northern part, while monitoring stations near 
2013 2014 2015 2016 2017
Chinese grade II 24-h target (75 μg/m³)
Number of days target not attained 153 163 142 132 85
Number of cases 6095 4269 5042 1851 2714
Health-care cost*, million ¥ 108·4 76·6 93·2 34·5 48·2
Chinese grade I 24-h target (35 μg/m³)
Number of days target not attained 275 270 255 240 212
Number of cases 11 030 7487 8876 3524 6020
Health-care cost*, million ¥ 196·2 134·4 164·1 65·6 107·0
WHO 24-h target (25 μg/m³)
Number of days target not attained 298 301 287 281 256
Number of cases 12 679 8529 10 237 4122 7377
Health-care cost*, million ¥ 225·5 153·1 189·3 76·7 131·1
COPD=chronic obstructive pulmonary disease. ¥=Chinese yuan. *Number of estimated cases multiplied by mean 
average health-care cost of each case of acute exacerbation of COPD in that year in Beijing. Average health-care cost 
(inflation-adjusted) for each case of acute exacerbation of COPD each year was extracted from the same hospital 
discharge database operated by Beijing Public Health Information Centre. The average health-care cost for each case of 
acute exacerbation of COPD in Beijing was ¥17 790·2 in 2013, ¥17 948·0 in 2014, ¥18 489·4 in 2015, ¥18 616·4 in 
2016, and ¥17 778·8 in 2017.
Table 3: Number of cases of acute exacerbation of COPD advanced by PM2·5 pollution above the expected 
rates if daily PM2·5 concentrations had not exceeded the standard 24-h targets each year
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traffic or in the city centre have (as expected) the highest 
concentrations of some pollutants.36 In addition, con-
founding factors operate at the area level across the city, 
which might also affect the spatial variations of the health 
effects. For example, a study in Beijing reported that, 
despite the lower air pollution concentration in suburban 
and rural areas compared with urban areas, cardiovascular 
mortality risk in relation to air pollution was higher in 
suburban and rural areas than in urban areas.37 Although 
different compositions of air pollutants across the areas 
probably contribute to this effect, factors such as access 
to quality health care, age structure of populations, and 
availability of protection measures also contribute. 
Beyond the scope of this study, a separate, careful investi-
gation involving the collection of station-specific air 
quality data and contextual area-level data would be 
needed to understand the spatial variations of acute 
exacerbations of COPD risks in Beijing.
This is by far the largest time-series study in China to 
study the short-term effects of air pollution on 
hospitalisations for acute exacerbations of COPD among 
the whole population of Beijing at a time when various 
measures were being implemented to reduce air pol-
lution. Our study had some limitations. First, because 
this was an ecological analysis in which individual-level 
confounding factors were not considered, modelled 
estimates should not be interpreted as predictive of 
individual hospitalisation probability. Some factors are 
unlikely to change over a short period, but time-varying 
factors such as seasonal viral or bacterial infection 
patterns might confound the studied relationships. 
Second, we only had data on daily, outdoor, city-wide 
average concentrations of each air pollutant, which 
we correlated with daily hospitalisations for acute exacer-
bation of COPD in the whole of Beijing. This method 
will have introduced bias to health estimates because 
place of residence and time-activity (eg, time spent 
indoors, including in the home and workplace, and the 
associated exposures to indoor sources) were not taken 
into account. People spend most of their time indoors, 
and outdoor pollution does penetrate indoors but 
with variable infiltration efficiency. This exposure mis-
classification is likely to underestimate, although 
not necessarily invalidate, the effect estimate.38,39 
Furthermore, assigning estimates from the nearest 
monitoring station to residence did not necessarily 
improve the correlation between personal exposures and 
ambient concentrations.40 Ongoing studies41 using 
personal air pollution monitoring will be useful to bridge 
this gap. Third, our study outcome was confirmed 
hospitalisation for acute exacerbation of COPD, which 
might only represent the most severe cases. Air pollution 
can also have specific effects on different types of 
exacerbations,42 and these effects should be investigated 
further if data became available. Fourth, as the air 
pollution concentration in Beijing was in decline over the 
study years, there might have been fewer deaths among 
patients with COPD9 and thus the existing COPD 
populations might have increased in size, which could 
have affected our estimates. Finally, other than effective 
emission control measures, trends in economic develop-
ment, meteoro logical conditions, and health care might 
all contribute to air quality and health manage ment,43 
and these contributions should be carefully considered 
in future investigations.
In conclusion, acute exposures to both particulate and 
gaseous pollutants were significantly associated with 
hospitalisations for acute exacerbation of COPD in 
Beijing. Although the APPCAP has shown positive 
effects in terms of reducing air pollution and COPD 
morbidity in our study population, the concentrations 
of  ambient air pollution are still dangerously high, 
warranting continued collective mitigation measures to 
achieve substantial health benefits.
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